Getbig Bodybuilding, Figure and Fitness Forums
December 13, 2017, 01:42:43 AM *
Welcome, Guest. Please login or register.

Login with username, password and session length
 
   Home   Help Login Register  
Pages: [1]   Go Down
  Print  
Author Topic: Nandrolon (Deca) can trigger ALS?  (Read 1253 times)
Christo
Getbig II
**
Posts: 250


« on: July 05, 2017, 12:30:47 PM »


Looks like AAS and specially Deca can trigger the muscle disease ALS...
Thats bad news guys

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272141/

Report to moderator   Logged
OlympiaGym
Getbig III
***
Posts: 879


« Reply #1 on: July 05, 2017, 06:10:46 PM »

Lou Gehrig was a notorious juicer.
Report to moderator   Logged
heenok
Getbig IV
****
Posts: 1326



« Reply #2 on: July 06, 2017, 03:51:07 AM »

I have a feeling 19-nor compound mess with the brain somewhat.
Report to moderator   Logged
Christo
Getbig II
**
Posts: 250


« Reply #3 on: July 06, 2017, 04:11:19 AM »

I have a feeling 19-nor compound mess with the brain somewhat.
[/quoftp://te]

Why? serious question. there are relatively many football players and soccer players in Europe which get ALS
Deca is quite populair in this kind of sports...

Report to moderator   Logged
falco
Getbig V
*****
Gender: Male
Posts: 11518


Iron is your best friend.


« Reply #4 on: July 06, 2017, 06:43:35 AM »

This has to be a lie! Gh15 clearly stated that steroids improve your health! Read the bible!!!
Report to moderator   Logged
Christo
Getbig II
**
Posts: 250


« Reply #5 on: July 07, 2017, 02:50:12 AM »

This has to be a lie! Gh15 clearly stated that steroids improve your health! Read the bible!!!

Read the academic article attached falco
Report to moderator   Logged
falco
Getbig V
*****
Gender: Male
Posts: 11518


Iron is your best friend.


« Reply #6 on: July 07, 2017, 05:24:48 AM »

Read the academic article attached falco

I did, but nothing beats the word of a steroid dealer.
Report to moderator   Logged
Genetic Freak
Getbig I
*
Posts: 13


« Reply #7 on: July 16, 2017, 02:54:40 AM »

I have a feeling 19-nor compound mess with the brain somewhat.

That seems to be the case:

There was a recent study published in 2015 in Toxicology and Applied Pharmacology which found that intramuscular (IM) doses of 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) in adult rats resulted in neurodegeneration.

The study administered IM injections of trenbolone to several groups of male and female rats over the course of 48 hours at time points of 0.5 h, 2 h, 6 h, 12 h, and 48 h. All rat groups with exception of the control group and pregnant females were treated with a solution of 1.0 and 0.2 mg/ml of trenbolone. The largest dose in the experiment was 5 mg/ml and was administered to the pregnant female rats. As such, when a conversion is done to adjust for dose to weight ratio, the equivalent dose in humans is approximately 0.85 mg/kg of body weight which for a 85 kg (187 lb) male translates to 72.25 mg of trenbolone (depending on dosing this is within an average range for a user). The study also cultured primary hippocampal neurons and treated them with trenbolone to assess effects in vitro.1

Anyway, skipping to the results, it was shown that Aβ42 levels were altered both in vivo as well as in vitro in response to trenbolone administration. An increase in Aβ42 concentration in the brain and hippocampus leads to aggregation and deposition, thereby damaging neurons. Of note, the level of Aβ42 concentration was found to be higher in the male rats. Why? Well, one hypothesis is that sex differences in the protein concentration are due to estrogen (E2) levels Ė estrogen levels are higher in females and estrogen is known to reduce Aβ accumulation.1

What is Aβ42:
Well, Aβ (amyloid beta) is a senile plaque Aβ protein that ends in residue 40 or 42 that is critical to the pathogenesis of Alzheimerís disease. Aβ42 only makes up less that 10% of total AB, however, it aggregates at a much faster rate than Aβ40. It is the initial and major component of senile plaque deposits, and observation of the Aβ42/ Aβ40 ratio is a reliable biomarker for development of Alzheimerís disease.2

As you can see, increasing the concentration of this protein in the brain isnít something that we want to do. In the primary hippocampal neuron cultures, the trenbolone induced apoptosis of the hippocampal neurons (apoptosis is programmed cell death) which is the hallmark feature of both acute and chronic neurodegenerative diseases. Keep in mind too that this trial only consisted of two days of treatment, and that most AAS cycles involving trenbolone range anywhere from 8-12 weeks long. Iím not saying that if you use trenbolone you will absolutely end up with Alzheimerís disease or some form on dementia, however, there is a good chance that you are increasing your risk of heightened Aβ42 aggregation. Damage to neurons often times occurs much earlier than the clinical symptoms of neurodegenerative disorders present themselves, and as such itís possible that damage has already unknowingly been done.

Just some food for thought..


1http://www.ncbi.nlm.nih.gov/pubmed/25461682
2http://www.ncbi.nlm.nih.gov/pubmed/23571809
Report to moderator   Logged
Pages: [1]   Go Up
  Print  
 
Jump to:  

Theme created by Egad Community. Powered by MySQL Powered by PHP Powered by SMF 1.1.20 | SMF © 2013, Simple Machines Valid XHTML 1.0! Valid CSS!